Rian J. Dickstein, M.D.

Medical Director, Bladder Cancer Program, Chesapeake Urology

Dr. Dickstein serves as the Medical Director of the Bladder Cancer Program at Chesapeake Urology, a United Urology Group affiliate. He is also a member of the Bladder Cancer Advocacy Network (BCAN) Scientific Advisory Board, which is composed of distinguished leading academic urologists, oncologists, radiation oncologists, and pathologists working within the bladder cancer field, representing many of the major cancer centers in the U.S and Canada.

Dr. Dickstein focuses on all urologic cancers and specializes in open, laparoscopic, and robotic surgeries. His expertise includes the treatment of bladder cancer (non-invasive and locally advanced), kidney cancer (small or locally advanced tumors), and prostate cancer (including primary and salvage surgery for complex cases). Dr. Dickstein also specializes in the treatment of testicular and penile cancers. He has published numerous articles on urologic cancers in multiple medical journals and has presented at national meetings on subjects primarily related to bladder and penile cancers. He also serves as Chief of Urology, University of Maryland Baltimore Washington Medical Center; Cancer Liaison Physician for the Tate Cancer Center at The University of Maryland Baltimore Washington Medical Center​; and Clinical Assistant Professor, Department of Surgery at University of Maryland School of Medicine.

Dr. Dickstein received his medical degree from Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, completed his Urology Residency and General Surgery Internship at Boston Medical Center (Boston University). Dr. Dickstein also completed a Urologic Oncology Fellowship at The University of Texas MD Anderson Cancer Center.